Safety and tolerability of Empagliflozin use during the holy month of Ramadan by fasting patients with type 2 diabetes: A prospective cohort study.
Samkari MM, Bokhari NS, Alhajaji R, Ahmed ME, Al Raddadi A, Bahget AK, Saleh SF, Aljehani F, Alzahrani SH, Alsifyani SS, Samkari MM, Badr AF, Alalawi M, Al Sulaiman K.
Samkari MM, et al. Among authors: saleh sf.
Saudi Pharm J. 2023 Jun;31(6):972-978. doi: 10.1016/j.jsps.2023.04.022. Epub 2023 Apr 28.
Saudi Pharm J. 2023.
PMID: 37234349
Free PMC article.